CLPBY

1 Day 1D

5 Days 5D

1 Month 1M

6 Months 6M

YTD YTD

1 Year 1Y

5 Years 5Y

About Coloplast AS

CEO
Kristian Villumsen
Employees
0
Headquarters

Holtedam 1 3, Humlebaek 3050
Phone: 4549111111
https://www.coloplast.dk/

News

Coloplast A/S (CLPBF) Q4 2023 Earnings Call Transcript
Nov 13, 2023 02:45am

Coloplast A/S (OTCPK:CLPBF) Q4 2023 Earnings Conference Call November 9, 2023 5:00 AM ETCompany ParticipantsKristian Villumsen - President and Chief…


Source:Seeking Alpha
Coloplast A/S 2023 Q4 - Results - Earnings Call Presentation
Nov 09, 2023 15:40pm

The following slide deck was published by Coloplast A/S in conjunction with their 2023 Q4 earnings call.


Source:Seeking Alpha
European shares gain on earnings boost; investors await cues on policy outlook
Nov 09, 2023 09:42am

By Ankika Biswas (Reuters) -European shares rose on Thursday, boosted by AstraZeneca and Adyen on strong earnings, while markets awaited the Federal Reserve Chair’s remarks on the monetary policy outlook after European Central Bank officials played down market bets around rate cuts. The pan-European STOXX 600 was up 0.2% by 0904 GMT after touching a three-week high intraday in the prior session. Markets are once again bracing for Powell’s remarks, scheduled for 1900 GMT, a day after he refrained from commenting on interest rates. “Powell is quite comfortable with the message already sent- rate-hiking cycle has likely come to an end but that talk of cuts is premature,” said Stuart Cole, head macro economist at Equiti Capital. ECB policymakers on Wednesday said further progress is needed to tame inflation, while Vice President Luis de Guindos in an interview on Thursday said it is premature to discuss rate cuts amid lingering risks to the inflation outlook. Bank of England Chief Economist Huw Pill also noted the central bank needed to maintain a restrictive stance for monetary policy, a day after Governor Andrew Bailey pushed back against discussions on rate cuts. “One clear take-away is that nothing is expected until at least the middle of next year; the question is whether it will come late H1/early H2, or late H2,” Equiti’s Cole said.


Source:SRN News
Coloplast A/S: Coloplast announces new manufacturing site in Portugal
Nov 09, 2023 06:46am

Coloplast, a leading company within intimate healthcare, will invest around 100 million euros in a new manufacturing site in Portugal to support the company''s continued growth. The new manufacturin…


Source:Finanz Nachrichten
Coloplast announces new manufacturing site in Portugal
Nov 09, 2023 06:39am

Coloplast, a leading company within intimate healthcare, will invest around 100 million euros in a new manufacturing site in Portugal to support the company’s continued growth.


Source:GlobeNewswire
Coloplast Offers A Fortress Business But At A Fort Knox Price
Oct 12, 2023 09:03am

Coloplast''s recent acquisitions may boost growth but come with noticeable margin dilution in the near term. Find out why CLPBF stock is a Hold.


Source:Seeking Alpha